Latest Market News

Feb 12
Roundtable of the EC on the review of the EU benchmark regulation

The Chairman of the FSMA, Jean-Paul Servais, was invited by the European Commission to speak at a panel discussion organized as part of a roundtable on the review of the Benchmark Regulation (BMR). The subject of the discussion was the IBOR review and the extent to which the framework created for the BMR gives supervisory […]

Feb 12
Speech on financial education

The Chairman of the FSMA, Mr Jean-Paul Servais, gave a speech at the Investment Management Forum organized by EFAMA (European Fund and Asset Management Association). During his remarks, the Chairman stressed the importance of financial education. He also outlined the initiatives that the FSMA has already taken via its financial education programme, Wikifin, and in […]

Feb 12
Approval of the modified market rules of the regulated markets organized by Euronext NV/SA

The Financial Services and Markets Authority (FSMA) hereby announces that the modified market rules of the regulated markets organized by Euronext NV/SA (namely Euronext Brussels and the Euronext Brussels Derivative Instruments Market) were approved on 19 November 2019 in accordance with Article 34, § 1 of the Law of 21 November 2017 on the market […]

Feb 12
The second-pillar pension in images – sectoral overview 2019

This press release is not available in English, please consult the French or Dutch site. Source: FSMA

Feb 12
Press release on the reopening of trading in ASIT biotech

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of ASIT biotech, ISIN BE0974289218 on Euronext Brussels will re-open on 25/11/2019 at 09:00 CET. Source: FSMA

Feb 12
Agreed settlement – CVBA N Allo

This press release is not available in English. Please consult the French or Dutch site. Source: FSMA